A detailed history of Tower Research Capital LLC (Trc) transactions in Argenx Se stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 960 shares of ARGX stock, worth $603,187. This represents 0.01% of its overall portfolio holdings.

Number of Shares
960
Previous 1,147 16.3%
Holding current value
$603,187
Previous $493,000 5.48%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $81,199 - $103,205
-187 Reduced 16.3%
960 $520,000
Q2 2024

Aug 13, 2024

BUY
$356.01 - $451.55 $350,669 - $444,776
985 Added 608.02%
1,147 $493,000
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $296,268 - $343,030
-830 Reduced 83.67%
162 $63,000
Q4 2023

Feb 13, 2024

BUY
$338.91 - $506.01 $26,773 - $39,974
79 Added 8.65%
992 $377,000
Q3 2023

Nov 14, 2023

SELL
$369.35 - $548.43 $695,486 - $1.03 Million
-1,883 Reduced 67.35%
913 $448,000
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $910,433 - $1.07 Million
2,528 Added 943.28%
2,796 $1.09 Million
Q1 2023

May 09, 2023

SELL
$334.23 - $403.65 $112,969 - $136,433
-338 Reduced 55.78%
268 $100,000
Q4 2022

Feb 10, 2023

SELL
$342.17 - $402.31 $248,073 - $291,674
-725 Reduced 54.47%
606 $229,000
Q3 2022

Nov 10, 2022

SELL
$343.2 - $395.75 $168,168 - $193,917
-490 Reduced 26.91%
1,331 $469,000
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $6,200 - $8,714
23 Added 1.28%
1,821 $689,000
Q1 2022

May 12, 2022

BUY
$254.45 - $351.06 $163,102 - $225,029
641 Added 55.4%
1,798 $567,000
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $155,589 - $201,933
-572 Reduced 33.08%
1,157 $405,000
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $533,065 - $633,498
-1,807 Reduced 51.1%
1,729 $522,000
Q2 2021

Aug 16, 2021

BUY
$257.11 - $319.92 $764,130 - $950,802
2,972 Added 526.95%
3,536 $1.07 Million
Q1 2021

May 17, 2021

BUY
$268.3 - $380.31 $37,025 - $52,482
138 Added 32.39%
564 $155,000
Q4 2020

Feb 16, 2021

BUY
$248.13 - $308.36 $9,428 - $11,717
38 Added 9.79%
426 $125,000
Q3 2020

Nov 16, 2020

SELL
$215.51 - $272.51 $82,324 - $104,098
-382 Reduced 49.61%
388 $102,000
Q2 2020

Aug 13, 2020

SELL
$127.44 - $232.72 $46,005 - $84,011
-361 Reduced 31.92%
770 $173,000
Q1 2020

May 15, 2020

BUY
$108.83 - $165.23 $69,215 - $105,086
636 Added 128.48%
1,131 $149,000
Q4 2019

Feb 07, 2020

BUY
$106.59 - $164.21 $18,440 - $28,408
173 Added 53.73%
495 $79,000
Q3 2019

Nov 05, 2019

BUY
$113.31 - $150.51 $36,485 - $48,464
322 New
322 $37,000
Q2 2019

Aug 13, 2019

SELL
$115.0 - $141.58 $1,955 - $2,406
-17 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$98.85 - $134.59 $1,680 - $2,288
17 New
17 $2,000
Q3 2018

Nov 13, 2018

SELL
$75.5 - $96.63 $19,101 - $24,447
-253 Closed
0 $0
Q2 2018

Aug 15, 2018

SELL
$74.84 - $100.16 $31,582 - $42,267
-422 Reduced 62.52%
253 $21,000
Q1 2018

May 15, 2018

BUY
$56.95 - $85.19 $38,441 - $57,503
675 New
675 $54,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.